Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Integrin
    (1)
  • MAO
    (1)
  • Monoamine Oxidase
    (1)
  • NF-κB
    (1)
  • Rho
    (1)
  • Vasopressin Receptor
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

ogd/r

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    8
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Recombinant Protein
    8
    TargetMol | Recombinant_Protein
  • Antibody Products
    2
    TargetMol | Antibody_Products
Safinamide mesylate
FCE28073 mesylate, EMD 1195686 mesylate
T6651202825-46-5
Safinamide mesylate (EMD 1195686 mesylate) , a mesylate salt of Safinamide, can reversibly and specifically inhibit MAO-B (IC50: 98 nM), has 5918-fold selectivity against MAO-A.
  • Inquiry Price
Size
QTY
GGTI 2147
GGTI2147, Geranylgeranyl transferase inhibitor-2147, GGTI-2147
T25450191102-87-1In house
GGTI 2147 decreased Rac1 activity, down-regulated p65 expression, and ameliorated OGD R-induced neuronal apoptosis.
  • Inquiry Price
8-10 weeks
Size
QTY
ATN-161 acetate
Ac-PHSCN-NH2 acetate, ATN161 acetate, ATN-161 acetate(262438-43-7 Free base)
T10398L904763-58-2
ATN-161 acetate, a pentapeptide compound derived from the synergistic region of fibronectin, is a non-competitive integrin-alpha5 antagonist with antitumor activity that attenuates the pathology of caerulein-induced acute pancreatitis.
  • Inquiry Price
Size
QTY
Terlipressin Acetate
Terlipressin acetate anhydrous
T13920L1884420-36-3
Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation re-oxygenation (OGD R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
  • Inquiry Price
Size
QTY
Neuroprotective agent 6
T200852
Neuroprotective agent 6 (Compound Y12) functions as an antioxidant and displays prominent neuroprotective effects in both oxygen-glucose deprivation reperfusion (OGD R) induced cell models and transient middle cerebral artery occlusion (tMCAO) induced animal models. Additionally, this compound shows significant metal chelating activity towards Cu2+.
  • Inquiry Price
Size
QTY
PDPOB
T605282351900-45-1
PDPOB (phenyl carboxylic acid derivative) shows potential for cerebral ischemia studies by protecting SH-SY5Y cells against OGD R-evoked neuronal deterioration, reducing mitochondrial dysfunction, oxidative stress, and apoptosis [1].
  • Inquiry Price
6-8 weeks
Size
QTY
Anti-MI/R injury agent 1
T830432387506-35-4
Anti-MI R injury agent 1 (compound 18), derived from Panaxatriol, is an orally administered, potent agent against myocardial ischemia reperfusion (MI R) injury. It improves cell viability in cardiomyocytes subjected to oxygen-glucose deprivation and reperfusion (OGD R)-induced injury, significantly reduces myocardial infarction size, diminishes levels of circulating cardiac troponin I (cTnI), and mitigates cardiac tissue damage in rat models [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Ferroptosis-IN-10
T89185
Ferroptosis-IN-10 (compound D1) is an inhibitor of ferroptosis, demonstrating a potent IC50 value of 22 nM. It exhibits neuroprotective activity in the oxygen-glucose deprivation reoxygenation (OGD R) model.
  • Inquiry Price
Size
QTY